APA (7th ed.) Citation

Trefond, L., Drumez, E., Andre, M., Costedoat-Chalumeau, N., Seror, R., Devaux, M., . . . Hachulla, E. (2021). Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases. Joint, bone, spine : revue du rhumatisme, 88(6), 105226-4. https://doi.org/10.1016/j.jbspin.2021.105226

Chicago Style (17th ed.) Citation

Trefond, Ludovic, et al. "Impact of Hydroxychloroquine Used as DMARD on SARS-CoV-2 Tests and Infection Evolution in a Population of 871 Patients with Inflammatory Rheumatic and Musculoskeletal Diseases." Joint, Bone, Spine : Revue Du Rhumatisme 88, no. 6 (2021): 105226-4. https://doi.org/10.1016/j.jbspin.2021.105226.

MLA (9th ed.) Citation

Trefond, Ludovic, et al. "Impact of Hydroxychloroquine Used as DMARD on SARS-CoV-2 Tests and Infection Evolution in a Population of 871 Patients with Inflammatory Rheumatic and Musculoskeletal Diseases." Joint, Bone, Spine : Revue Du Rhumatisme, vol. 88, no. 6, 2021, pp. 105226-4, https://doi.org/10.1016/j.jbspin.2021.105226.